相关实验视频
Updated: Jun 18, 2025

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
111.5K
为什么Wnt/β-catenin尚未成为常规癌症治疗的目标?
Auriane de Pellegars-Malhortie1, Laurence Picque Lasorsa1, Thibault Mazard1,2
1IRCM (Montpellier Cancer Research Institute), University of Montpellier, Inserm, ICM (Montpellier Regional Cancer Institute), 34298 Montpellier, CEDEX 5, France.
Pharmaceuticals (Basel, Switzerland)
|July 27, 2024
概括
针对Wnt/β-catenin通路提供了新的癌症治疗选择. 然而,平衡抗癌效应与毒性仍然是Wnt/β-catenin抑制剂面临的挑战.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物开发 药物开发
背景情况:
- 有限的治疗选择阻碍了癌症治愈率.
- Wnt/β-catenin信号通路对癌症至关重要,但也对组织平衡至关重要.
- 针对这种途径为新型癌症疗法提供了一个有希望的途径.
研究的目的:
- 审查Wnt/β-catenin路径抑制剂的临床试验.
- 分析它们的抗瘤活性和不良事件.
- 探索改善其治疗效益风险概况的策略.
主要方法:
- 临床试验数据的系统审查.
- 对抗瘤功效和毒性概况的分析.
- 检查新出现的减轻副作用的策略.
主要成果:
- Wnt/β-catenin抑制剂显示出有前途的效果,但尚未成为标准护理.
- 治疗指数受到对健康组织的毒性限制.
- 提高选择性和减少副作用的策略正在开发中.
结论:
- 抑制Wnt/β-catenin通路是癌症治疗的一个发展领域.
- 改善治疗指数对于临床成功至关重要.
- 需要对有针对性的输送和组合疗法的进一步研究.
相关概念视频
Catenins
2.3K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.3K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Cadherins in Tissue Organization
3.0K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.0K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

